ROBERT CARR: Open Payments
NPI 1720596521 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 28 payments from 11 companies in 2025. Trend: 2023 $378 · 2024 $546 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $204 |
| Optinose US, Inc. | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| GENZYME CORPORATION | 2 | $54 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Medtronic, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: NUCALA, Xhance, DUPIXENT, Rhapsido, NEFFY, PROPEL, TEZSPIRE, WatchPATONE.
Industry payments across FL — which companies pay providers there.
